Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2012 Jul 24.
Published in final edited form as: Tetrahedron Lett. 2010 Aug 30;51(44):5757–5760. doi: 10.1016/j.tetlet.2010.08.089

Synthesis of Hemigossypol and its Derivatives

Jun Wei a,#, David L Vander Jagt b, Robert E Royer b, Lorraine M Deck a,*
PMCID: PMC3403735  NIHMSID: NIHMS237740  PMID: 22837586

Abstract

Hemigossypol (3), a sesquiterpene natural product, was previously isolated from Gossypium barbadense and was shown to display improved anti-fungal activity compared to gossypol (1), the disesquiterpene dimer of hemigossypol (3). Gossypol exhibits multiple biological activities. In order to study whether hemigossypol and it derivatives retain the various bioactivities of gossypol, we developed a short and convenient synthetic scheme to synthesize hemigossypol. This is the first de novo synthesis of this natural product. In addition derivatives of hemigossypol with various 2,5-alkyl substituents were synthesized. Modification of the synthetic scheme also afforded the natural product hemigossylic lactone (4) and its 2,5-substituted derivatives.

Keywords: Hemigossypol, gossypol, hemigossylic lactone


Gossypol (1), a natural product from cottonseed, is a disesquiterpene exhibiting atropisomerism owing to restricted rotation around the binaphthyl bond (Figure 1). Gossypol exhibits multiple biological properties, including spermicidal,1 antiparasitic,2 anticancer,3 and antiviral activities.4 Gossypol displays potent inhibition against anti-apoptotic Bcl-2 family proteins where it functions as a BH3 mimic.5 (−)-Gossypol is currently in phase II clinical trails, displaying single-agent antitumor activity in patients with advanced malignancies.6,7 Multiple bioactivities of gossypol have stimulated wide interest in the development of gossypol derivatives to explore structure-activity relationships.813 We have previously reported that gossylic lactone (2)9 (Figure 1), in which the aldehyde groups of gossypol that contribute to toxicity have been modified, retains antimalarial activity and exhibits enhanced inhibitory activity compared to gossypol against aldose reductase, an enzyme implicated in the etiology of diabetic complications.9,14

Figure 1.

Figure 1

The question of interest is whether hemigossypol (3) and hemigossylic lactone (4) (Figure 1), the monomers of gossypol and gossylic lactone, respectively, still retain the various bioactivities of gossypol. Hemigossypol, a natural product isolated from the verticillium-infected stele tissue of Gossypium barbadense,15 is at least three-fold more toxic to the cotton seedling disease pathogen, Rhizoctonia solani, than gossypol.16 Furthermore, it was reported that methylated hemigossypol displayed comparable spermicidal activity as gossypol.17 Hemigossylic lactone with a methoxy group on position six is a natural product isolated from the root bark of B. malabarium;18 however, bioactivity has not been reported. In order to explore SAR of hemigossypol and hemigossylic lactone, we developed a short and convenient synthetic scheme to synthesize hemigossypol and its 2,5-alkyl substituted derivatives. Modification of the synthetic scheme also afforded hemigossylic lactone and its 2,5-alkyl substituted derivatives.

Synthetic Scheme 1 features the incorporation of the carbon atoms for the second ring of the naphthalene system in one step by the reaction of the Grignard reagent formed from 1-bromo-2-isopropyl-3,4-dimethoxybenzene (5a) and 1-bromo-3,4-dimethoxy-2-propylbenzene (5c) with ethyl 3-methyl-4-oxobutanoate (6a) and ethyl 2,3-dimethyl-4-oxobutanoate (6b) to form lactones 7a, 7b and 7c in 63–70% yield.19 The precursor bromides are readily prepared from commercially available starting materials using procedures described in the literature.20, 21, 22 In some preparations of the bromides using the Edward's procedure22 small amounts (5 to 10%) of the isomeric bromides 5-bromo-3-alkyl-1,2-dimethoxybenzene were formed.23 An alternate highly regioselective silica gel catalyzed bromination, using N-bromosuccinimide proved more effective.24 The precursors ethyl 3-methyl-4-oxobutanoate (6a) and ethyl 2,3-dimethyl-4-oxobutanoate (6b) were prepared by a Horner-Emmons-Wadsworth reaction followed by hydrogenation of the alkene bond and hydrolysis of the resulting acetal as previously described.25, 26 In our hands hydrogenation using palladium on charcoal resulted in loss of a methoxy group of the acetal but use of palladium on calcium carbonate gave the desired acetal, which was then hydrolyzed.

Scheme 1.

Scheme 1

Synthesis of hemigossypol: Reagents and conditions: (a) Mg (3 equiv), BrCH2CH2Br (0.1 equiv), THF, reflux, 1.0 h then 6 (1.2 equiv), 0°C to rt, 12 h, H2O/HCl, rt, 5 h, 70% of 7a, 66% of 7b, 63% of 7c. (b) concentrated sulfuric acid, rt, 60°C, 2.0 h, 5%. (c) BBr3 (5 equiv), CH2Cl2, 2.0 h, −78°C, 24 h, rt, 90% of 9a, 70% of 9b, 81% 9c. (d) TiCl4 (5 equiv), Et2O/CH2Cl2, 0°C, 15 min, then Cl2CHOCH3 (2 equiv), 0°C, 3 h, rt, 18 h, 16% of 3a, 10% of 3b, 20% of 3c, and 4% of 10a, 34% of 10b, 25% of 10c; or 9b, hexamethylenetetramine (0.5 equiv), HAc, 100°C, 1.0 h, then H2SO4/H2O, 60°C, 2 h, 25% 10b (e) CH3CN/H2O, 6M HCl, rt, 18 h, 90% of 3b, 100% of 3c. (f) BBr3 (7 equiv), CH2Cl2, 0°C, then reflux 3 h, 0°C, CH(OC2H5)3 (6 equiv), reflux, 1.0 h, rt, 24 h, 10%. of 10b from 7b, 10% of 10c from 7c. (g) BBr3 (5 equiv), CH2Cl2, 0°C, reflux, 3 h, then CH(OC2H5)3 (6 equiv), 0°C, reflux, 1 h, rt, 24 h, 25%. (h) (CH3O)2SO2 (6.5 equiv), K2CO3 (6.5 equiv), (CH3)2C=O, reflux, 24 h, 90%.

In the synthesis of gossypol performed by Venuti27 compound 5a was transformed to naphthalenol compound 8 in six steps. In one of the steps Venuti proposed compound 7a as an intermediate, but it was never isolated. We envisioned that lactone 7a could be converted to naphthalenol 8 in one step using a strong Lewis acid which would cause the opening of the lactone ring followed by Friedel Crafts cyclization of the resulting acid, dehydration and aromatization.28 Attempts using dilute hydrochloric acid, phosphorous trichloride or titanium tetrachloride failed and concentrated sulfuric acid afforded only 5% of product. However lactones 7a–7c were successfully converted to naphthalenols 9a–9c using boron tribromide in 70–90% yield.29 Compound 9a is slightly unstable and degrades during chromatography. The aldehyde group was introduced by formylation of naphthalenols 9a–9c with titanium tetrachloride and dichloromethyl methyl ether30,31 followed by hydrolysis, to successfully afford the natural product hemigossypol 3a and its derivatives 3b and 3c in moderate yield.32 The proton NMR spectrum of compound 3a generally agreed with the literature15. Anhydrohemigossypol 10a has been observed in the mass spectrum of hemigossypol15 and anhydrogossypol, the dimer of compound 10a, is well documented in the literature.33, 34 The proton NMR spectrum of anhydrohemigossypol 10a and its derivatives 10b and 10c is similar to that of anhydrogossypol.35 The anhydro compounds 10a–10c could be converted back to aldehydes 3a–3c using dilute hydrochloric acid in acetonitrile.

Alternate synthetic methods for the formation of compounds 3 from naphthalenols 9a and 9b were investigated in hopes of increasing the yield of product. Vilsmeier and N,N-diphenylformamidine methods did not afford product.36, 37, 38 The Duff reaction, which involves the use of hexamethylenetetramine in the presence of acetic acid, on compound 9b gave the dehydrated compound 10b in a 25% yield.39 These disappointing results led to the one pot reaction of compound 7a with boron tribromide followed by triethylorthoformate to give compound 11 in 25% yield.40 Unfortunately, compound 1141 is the 2-formyl regioisomer of compound 3 and its structure was verified by methylation to give the known compound 12.17 Using the same conditions on compound 7b, which has a methyl group in position two, 10% of compound 10b was obtained.

Since formylation of naphthalenols 9 resulted in poor yields of product, compounds 9a and 9b were methylated using dimethylsulfate to give compounds 13a and 13b.42 (Scheme 2). Formylation reactions on the the dimeric (5,5'-diisopropyl-1,1',6,6',7,7'-hexamethoxy-3,3'-dimethyl-2,2'-binaphthalene) and the monomeric form of compound 13a have been published by Meltzer.37 Meltzer found that bisformylation and concomitant loss of both isopropyl groups occurred on reaction of the dimeric form of compound 13a using titanium tetrachloride and dichloromethyl methyl ether. Identical treatment of the monomeric compound, 13a, resulted in formylation in the 8 position, peri to the isopropyl group. Using these same conditions we reacted compound 13b and obtained a mixture of products with the major product lacking an isopropyl group. Fortunately, formylation of compound 13a using t-butyllithium followed by the electrophile N-methylformanilide and hydrolysis gave a 49% yield of compound 14 (Scheme 2) whereas reaction of 13b using these conditions failed to give the desired product.17, 43 Demethylation of compound 14 with boron tribromide10 afforded an 80% yield of compound 3a.

Scheme 2.

Scheme 2

Synthesis of hemigossylic lactone and derivatives: Reagents and conditions: (a) (CH3O)2SO2 (13 equiv), K2CO3 (13 equiv), (CH3)2C=O, reflux, 85% of 13a and 13b. (b) t-BuLi (8 equiv), C6H12, 0°C, 18 h then HCON(CH3)C6H5 (2.5 equiv), 8 h, 49%. (c) BBr3 (3 equiv), CH2Cl2, −78°C, 1.0 h, 0°C, 1.0 h, rt, 1.0 h, 80%. (d) t-BuLi (7 equiv), C6H12, 0°C, then 18 h, rt, then ClCOOCH3 (19 equiv), −10°C, 8 h, 60% of 15a. (e) BBr3 (4 equiv), CH2Cl2, −78 C, 1.0 h, 0°C, 1.0 h, rt, 3 h, 6M HCl, reflux, 3 h, 80% of 4a and 71% 4c. (f) Br2 (1 equiv), CHCl3, 0°C, 2 h, 88% of 15c.

Synthesis of hemigossylic lactone 4a and its derivative, 4c, is similar to the synthesis of compound 14 except for the electrophile. Reaction of compound 13a with t-butyllithium followed by methylchloroformate resulted in ester 15a.44 Bromination of compound 15a gave bromide 15c.43, 45 The methyl ether groups in compounds 15 were readily removed using boron tribromide and the resulting mixtures were gently refluxed in dilute hydrochloric acid to undergo intramolecular lactonization and afford lactones 4a and 4c in 71–80% yield.46

A one step transformation from the readily available intermediate 7b to naphtholactone 16 is an attractive route to explore. Since lactones 7a–7c have been successfully converted to naphalenols 8 and 9a–9c in one step using Lewis acids (Scheme 1), we further envisioned that chlorosulfonyl isocyanate (CSI),47 a strong Lewis acid containing a reactive electrophilic isocyanate group, could convert lactone 7b into naphtholactone 16 in one step. Treatment of compound 7b with excess CSI followed by an acidic hydrolysis (Scheme 3) successfully afforded naphtholactone 16 in a 10% yield along with the unexpected amide compound 17 in 30% yield.48 We propose that initially the CSI acts as a Lewis acid and readily converts the lactone 7b to the 2-methylsubstituted naphthalenol adduct of compound 8. This naphthalenol adduct further reacts with the electrophilic carbonyl carbon in the CSI and hydrolysis using dilute acid causes intramolecular attack of the carbonyl by the peri hydroxyl group on position one resulting in formation of lactone 16. Amide 17 was formed by the reaction of CSI with the substituted naphthalenol at position four followed by acidic hydrolysis. Because of the brevity of this synthetic sequence and the promising results, reaction conditions are being investigated to improve the yield.

Scheme 3.

Scheme 3

Synthesis of dimethylhemigossylic lactones: Reagents and conditions: (a) ClSO2NCO (9 equiv), CH2Cl2, rt, 24 h, then HCl/H2O, EtOH, reflux, 1.0 h, 10% of 16 and 30% of 17.

In conclusion, a short and convenient synthetic scheme was developed to afford the bioactive natural product hemigossypol 3a and its 2, 5-substituted derivatives 3b and 3c. The modification of the synthetic scheme afforded hemigossylic lactones 4a and 4c as derivatives of the natural product 3-methylhemigossylic lactone. Bioactivities of hemigossypol, hemigossylic lactones and their derivatives are currently being investigated.

Acknowledgements

This research was supported in part by grant HL68598 from the National Institutes of Health. High resolution mass spectra (HRMS) were obtained at UNM Mass Spec Facility, Albuquerque, New Mexico.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • 1.Waller DP, Zaneveld LJ, Fong HH. Contraception. 1980;22:183–7. doi: 10.1016/0010-7824(80)90062-1. [DOI] [PubMed] [Google Scholar]
  • 2.Montamat EE, Burgos C, Gerez de Burgos NM, Rovai LE, Blanco A, Segura EL. Science. 1982;218:288–9. doi: 10.1126/science.6750791. [DOI] [PubMed] [Google Scholar]
  • 3.Jaroszewski JW, Kaplan O, Cohen JS. Cancer Res. 1990;50:6936–43. [PubMed] [Google Scholar]
  • 4.Dorsett PH, Kerstine EE, Powers LJ. J Pharm Sci. 1975;64:1073–5. doi: 10.1002/jps.2600640654. [DOI] [PubMed] [Google Scholar]
  • 5.Wang S, Yang D. US patent applications series no. 2003008924. 2002
  • 6.Meng Y, Tang W, Dai Y, Wu X, Liu M, Ji Q, Ji M, Pienta K, Lawrence T, Xu L. Mol Cancer Ther. 2008;7:2192–202. doi: 10.1158/1535-7163.MCT-08-0333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Van Poznak C, Seidman AD, Reidenberg MM, Moasser MM, Sklarin N, Van Zee K, Borgen P, Gollub M, Bacotti D, Yao TJ, Bloch R, Ligueros M, Sonenberg M, Norton L, Hudis C. Breast Cancer Res Treat. 2001;66:239–48. doi: 10.1023/a:1010686204736. [DOI] [PubMed] [Google Scholar]
  • 8.Royer RE, Deck LM, Campos NM, Hunsaker LA, Vander Jagt DL. J Med Chem. 1986;29:1799–801. doi: 10.1021/jm00159a043. [DOI] [PubMed] [Google Scholar]
  • 9.Deck LM, Vander Jagt DL, Royer RE. J Med Chem. 1991;34:3301–5. doi: 10.1021/jm00115a021. [DOI] [PubMed] [Google Scholar]
  • 10.Royer RE, Deck LM, Vander Jagt TJ, Martinez FJ, Mills RG, Young SA, Vander Jagt DL. J Med Chem. 1995;38:2427–32. doi: 10.1021/jm00013a018. [DOI] [PubMed] [Google Scholar]
  • 11.Deck LM, Royer RE, Chamblee BB, Hernandez VM, Malone RR, Torres JE, Hunsaker LA, Piper RC, Makler MT, Vander Jagt DL. J Med Chem. 1998;41:3879–87. doi: 10.1021/jm980334n. [DOI] [PubMed] [Google Scholar]
  • 12.Wei J, Kitada S, Rega MF, Emdadi A, Yuan H, Cellitti J, Stebbins JL, Zhai D, Sun J, Yang L, Dahl R, Zhang Z, Wu B, Wang S, Reed TA, Lawrence N, Sebti S, Reed JC, Pellecchia M. Mol Cancer Ther. 2009;8:904–13. doi: 10.1158/1535-7163.MCT-08-1050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Wei J, Rega MF, Kitada S, Yuan H, Zhai D, Risbood P, Seltzman HH, Twine CE, Reed JC, Pellecchia M. Cancer Lett. 2009;273:107–13. doi: 10.1016/j.canlet.2008.07.031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Brown WM, Yowell CA, Hoard A, Vander Jagt TA, Hunsaker LA, Deck LM, Royer RE, Piper RC, Dame JB, Makler MT, Vander Jagt DL. Biochemistry. 2004;43:6219–29. doi: 10.1021/bi049892w. [DOI] [PubMed] [Google Scholar]
  • 15.Bell AA, Stipanovic RD, Howell CR, Fryxell PA. Phytochemistry. 1975;14:225–231. [Google Scholar]
  • 16.Howell CR, Hanson LE, Stipanovic RD, Puckhaber LS. Phytopathology. 2000;90:248–52. doi: 10.1094/PHYTO.2000.90.3.248. [DOI] [PubMed] [Google Scholar]
  • 17.Manmade A, Herlihy P, Quick J, Duffley RP, Burgos M, Hoffer AP. Experientia. 1983;39:1276–7. doi: 10.1007/BF01990368. [DOI] [PubMed] [Google Scholar]
  • 18.Seshadri V, Batta AK, Rangaswami S. Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry. 1976;14B:616–617. [Google Scholar]
  • 19.Data for lactones 7: Dihydro-5-(2-isopropyl-3,4-dimethoxyphenyl)-4-methyl-2-furanone 7a: Yellow oil; 1H NMR (CDCl3, 250 MHz) δ 7.09 (d, J = 8.7 Hz, 1H), 6.79 (d, J = 8.7 Hz, 1H), 5.80 (d, J = 5.4 Hz, 1H), 3.87 (s, 3H), 3.86 (s, 3H), 2.89 (m, 2H), 2.34 (d, 1H), 1.34 (d, J = 6.4 Hz, 3H), 1.33 (s, 3H), 0.66 (d, J = 7.0 Hz, 3H); 13C NMR (CDCl3, 250 MHz) δ 176.1, 152.4, 148.2, 137.2, 125.6, 120.4, 109.7, 82.0, 60.3, 55.3, 37.8, 34.4, 28.4, 21.6, 21.2, 15.4. HRMS (EI) calcd for C16H22O4 [M+H]+ : 279.1596; found, 279.1592. Dihydro-5-(2-isopropyl-3,4-dimethoxyphenyl)-3,4-dimethyl-2-furanone 7b: Yellow oil; 1H NMR (CDCl3, 250 MHz) δ 7.11 (d, J = 8.7 Hz, 1H), 6.79 (d, J = 8.7 Hz, 1H), 5.66 (d, J = 5.4 Hz, 1H), 3.87 (s, 3H), 3.86 (s, 3H), 3.02 (m, 1H), 2.92 (m, 1H), 2.76 (m, 1H), 1.34 (t, J = 7.2 Hz, 6H), 1.21 (d, J = 7.2 Hz, 3H), 0.51 (d, J = 7.2 Hz, 3H); 13C NMR: δ 178.4, 152.4, 148.3, 137.2, 125.6, 120.7, 109.7, 80.6, 60.5, 55.4, 41.0, 39.5, 28.5, 21.6, 21.3, 10.0, 9.8. HRMS (EI) calcd for C17H24O4 [M+H]+ : 293.1753; found, 293.1744. Dihydro-5-(3,4-dimethoxy-2-propylphenyl)-3,4-dimethyl-2-furanone 7c: Yellow oil; 1H NMR (CDCl3, 250 MHz) δ 7.00 (d, J = 8.5 Hz, 1H), 6.79 (d, J = 8.7 Hz, 1H), 5.78 (d, J = 5.4 Hz, 1H), 3.87 (s, 3H), 3.86 (s, 3H), 2.75 (m, 1H), 2.55 (m, 1H), 2.31 (m, 1H), 1.34 (m, 6H), 1.23 (m, 3H), 0.65 (m, 3H); 13C NMR (CDCl3, 250 MHz) δ 179.2, 151.2, 146.6, 134.0, 120.6, 109.8, 103.2, 77.3, 68.3, 60.4, 55.4, 34.3, 28.3, 26.1, 24.2, 14.5, 12.9. HRMS (EI) calcd for C17H24O4 [M+H]+: 293.1753; found, 293.1751.
  • 20.Edwards JD, Cashaw JL. J. Org. Chem. 1955;20:847–849. [Google Scholar]
  • 21.Deck LM, Brazwell EM, Vander Jagt DL, Royer RE. Org. Prep. Proc. Int. 1990;22:495–500. [Google Scholar]
  • 22.Edwards JD, Jr., Cashaw JL. J. Am. Chem. Soc. 1956;78:3821–3824. [Google Scholar]
  • 23.Chin C, Tran DD, Shia K, Liu H. Synlett. 2005;3:417–420. [Google Scholar]
  • 24.Konishi H, Aritomi K, Okano T, Kiji J. Bull. Chem. Soc. Japan. 1989;62:591–593. [Google Scholar]
  • 25.Curley RW, Jr., Ticoras CJ. Synth. Commun. 1986;16:627–631. [Google Scholar]
  • 26.Meyers AI, Roth GP, Hoyer D, Barner BA, Laucher D. J. Am. Chem. Soc. 1988;110:4611–4624. [Google Scholar]
  • 27.Venuti MC. J. Org. Chem. 1981;46:3124–3127. [Google Scholar]
  • 28.Huang J, Su T, Watanabe KA. J. Org. Chem. 1991;56:4811–4815. [Google Scholar]
  • 29.Data for naphthalenols 9: 5-Isopropyl-3-methyl-1,6,7-naphthalenetriol 9a: Red oil; 1H NMR (CDCl3, 250 MHz) 1H NMR: δ 7.41 (s, 1H), 7.37 (s, 1H), 6.48 (s, 1H), 5.92 (br s, 2H), 5.40 (br s, 1H), 3.84 (m, 1H), 2.33 (s, 3H), 1.44 (d, J = 7.2 Hz, 6H); 13C NMR (CDCl3, 250 MHz) δ 143.1, 136.7, 135.4, 126.2, 122.7, 118.7, 110.9, 108.5, 102.0, 95.0, 19.8, 13.7, 7.9. HRMS (EI) calcd for C14H16O3 [M+H]+ : 233.1177; found, 233.1122. 5-Isopropyl-3,4-dimethyl-1,6,7-naphthalenetriol 9b: Light grey solid; mp 194–195 °C; 1H NMR: (Acetone-d6, 250 MHz) δ 8.87 (br s, 1H), 7.48 (s, 1H), 7.41 (s, 1H), 7.37 (br s, 1H), 7.15 (br s, 1H), 3.84 (m, 1H), 2.36 (s, 3H), 2.26 (s, 3H), 1.46 (d, J = 7.2 Hz, 6H); 13C NMR: (Methanol-d4, 250 MHz) δ 149.2, 145.2, 144.7, 133.3, 128.2, 125.7, 121.5, 116.8, 116.5, 102.8, 27.8, 21.5, 21.3, 12.2. HRMS (EI) calcd for C15H18O3 [M+H]+ : 247.1334; found, 247.1332. 3,4-Dimethyl-5-propyl-1,6,7-naphthalenetriol 9c: Light grey solid; mp 168–170 °C; 1H NMR: (Acetone-d6, 250 MHz) δ 9.29 (s, 1H), 7.79 (s, 1H), 7.45 (s, 1H), 7.44 (s, 1H), 7.19 (s, 1H), 2.96 (m, 2H), 2.34 (s, 3H), 2.24 (s, 3H), 1.63 (m, 2H), 1.00 (t, J = 7.4 Hz, 3H); 13C NMR: (Acetone-d6, 250 MHz) δ 148.9, 144.0, 143.3, 132.7, 127.8, 120.1, 120.0, 115.4, 115.2, 102.5, 27.4, 23.2, 20.9, 14.1, 11.8. HRMS (EI) calcd for C15H18O3 [M+H]+ : 247.1334; found, 247.1334.
  • 30.Rieche A, Gross H, Hoft E. Chem. Ber. 1960;93:88–94. [Google Scholar]
  • 31.Schuda PF, Price WA. J. Org. Chem. 1987;52:1972–1979. [Google Scholar]
  • 32.Data for hemigossypols 3: 2,3,8-Trihydroxy-4-isopropyl-6-methyl-1-naphthaldehyde 3a: Yellow solid; mp 158–160 °C (lit15 159–163 °C); 1H NMR (CDCl3, 250 MHz) δ 15.10 (s, 1H), 11.20 (s, 1H), 7.53 (s, 1H), 6.69 (s, 1H), 6.33 (s, 1H), 5.71 (s, 1H), 3.85 (m, 1H), 2.43 (s, 3H), 1.50 (d, J = 6.9 Hz, 6H); 13C NMR (CDCl3, 250 MHz): δ 199.3, 155.6, 151.6, 142.8, 134.2, 133.9, 129.5, 116.9, 114.4, 113.2, 111.6, 28.0, 21.6, 20.3. HRMS (EI) calcd for C15H16O4 [M+H]+ : 261.1127; found, 261.1172. 2,3,8-Trihydroxy-4-isopropyl-6,7-dimethyl-1-naphthaldehyde 3b: Yellow solid; mp 160–162 °C; 1H NMR (CDCl3, 250 MHz) δ 15.21 (s, 1H), 11.23 (s, 1H), 7.57 (s, 1H), 6.29 (s, 1H), 5.42 (s, 1H), 3.85 (m, 1H), 2.45 (s, 3H), 2.33 (s, 3H), 1.50 (d, J = 6.9 Hz, 6H); 13C NMR (CDCl3, 250 MHz) δ 199.2, 155.9, 149.5, 142.1, 134.1, 133.3, 126.9, 117.8, 117.4, 115.1, 113.4, 27.7, 20.0, 20.3, 11.8. HRMS (EI) calcd for C16H18O4 [M+H]+ : 275.1283; found, 275.1328. 2,3,8-Trihydroxy-6,7-dimethyl-4-propyl-1-naphthaldehyde 3c: Yellow solid; mp 194–195 °C; 1H NMR (CDCl3, 250 MHz) δ 8.47 (s, 1H), 7.29 (s, 1H), 7.05 (br s, 1H), 2.79 (t, J = 7.4 Hz, 2H), 2.47 (s, 3H), 2.44 (s, 3H), 1.70 (m, 2H), 1.03 (t, J = 7.4 Hz, 3H); 13C NMR (CDCl3, 250 MHz) δ 175.0, 152.4, 149.3, 149.0, 135.5, 126.5, 123.6, 122.6, 120.7, 118.6, 117.0, 27.7, 22.5, 19.9, 14.4, 12.0. HRMS (EI) calcd for C16H18O4 [M+H]+ : 275.1283; found, 275.1288.
  • 33.Miller RF, Adams R. J. Am. Chem. Soc. 1937;59:1736–1738. [Google Scholar]
  • 34.Jaroszewski JW, Hansen T. Chirality. 1992;4:216–221. [Google Scholar]
  • 35.Data for anhydrohemigossypols 10: 4-Hydroxy-5-isopropyl-7-methyl-3-naphtho[1,8-bc]furan-3-one 10a: Yellow oil; 1H NMR (CDCl3, 250 MHz) δ 8.48 (s, 1H), 7.50 (s, 1H), 7.31 (s, 1H), 7.27 (s, 1H), 3.52 (m, 1H), 2.56 (s, 3H), 1.50 (d, J = 7.3 Hz, 6H); 13C NMR (CDCl3, 250 MHz) δ 175.3, 152.3, 149.1, 148.8, 135.2, 130.7, 123.2, 123.0, 120.4, 118.6, 116.7, 27.1, 19.8, 12.0. HRMS (EI) calcd for C15H14O3 [M+H]+ : 243.1021; found, 243.0976. 4-Hydroxy-5-isopropyl-7,8-dimethyl-3-naphtho[1,8-bc]furan-3-one 10b: Brown solid; mp 192–193 °C; 1H NMR (CDCl3, 250 MHz) δ 8.50 (s, 1H), 7.49 (s, 1H), 7.22 (s, 1H), 3.46 (m, 1H), 2.49 (s, 3H), 2.49 (s, 3H), 1.50 (d, J = 6.9 Hz, 6H); 13C NMR (CDCl3, 250 MHz) δ 175.2, 152.5, 149.2, 148.8, 135.3, 130.8, 123.3, 123.1, 120.6, 118.6, 116.7, 27.1, 20.5, 19.9, 12.0. HRMS (EI) calcd for C16H16O3 [M+H]+ : 257.1177; found, 257.1176. 4-Hydroxy-7,8-dimethyl-5-propyl-3-naphtho[1,8-bc]furan-3-one 10c: Yellow solid; mp 163–165 °C; 1H NMR (CDCl3, 250 MHz) δ 15.17 (s, 1H), 11.24 (s, 1H), 7.35 (s, 1H), 6.12 (s, 1H), 5.38 (s, 1H), 3.02 (t, J = 7.6 Hz, 2H), 2.44 (s, 3H), 2.32 (s, 3H), 1.66 (m, 2H), 1.04 (t, J = 7.6 Hz, 3H); 13C NMR (CDCl3, 250 MHz) δ 200.1, 157.0, 151.1, 142.8, 134.8, 130.8, 128.1, 121.0, 117.8, 117.2, 112.8, 28.5, 23.3, 21.1, 14.6, 12.6. HRMS (EI) calcd for C16H18O4 [M+H]+: 257.1177; found, 257.1284.
  • 36.Moazzam M, Sana S, Rajanna KC. 2002;32:1351–1356. [Google Scholar]
  • 37.Meltzer PC, Bickford HP, Lambert GJ. J. Org. Chem. 1985;50:3121–3124. [Google Scholar]
  • 38.Edwards JD., Jr. J. Am. Chem. Soc. 1958;80:3798–3799. [Google Scholar]
  • 39.Smith ES. J. Org. Chem. 1972;37:3972–3973. [Google Scholar]
  • 40.Banerjee AK, Poon PS, Laya MS. Russ. J. Gen. Chem. 2003;73:1815–1820. [Google Scholar]
  • 41.Data for aldehyde 11: 1,6,7-Trihydroxy-5-isopropyl-3-methyl-2-naphthaldehyde: Yellow solid; mp 160–161 °C; 1H NMR (Acetone-d6, 500Hz) δ 13.69 (s, 1H), 10.24 (s, 1H), 7.64 (s, 1H), 7.33 (s, 1H), 3.83 (m, 1H), 2.67 (s, 3H), 1.45 (d, J = 7.3 Hz, 6H); 13C NMR (Acetone-d6, 500Hz) δ 195.2, 162.7, 149.0, 144.6, 133.2, 132.1, 126.0, 118.3, 115.3, 112.1, 104.3, 26.8, 20.3, 18.5. HRMS (EI) calcd for C15H16O4 [M+H]+: 261.1127; found, 261.1127.
  • 42.Data for compound 13b: 1-Isopropyl-2,3,5-trimethoxy-6,7-dimethyl-1-naphthalene: Oil; 1H NMR (CDCl3, 500Hz) δ 7.69 (s, 1H), 7.31 (s, 1H), 3.98 (s, 3H), 3.88 (s, 3H), 3.87 (m, 1H), 3.86 (s, 3H), 2.42 (s, 3H), 2.34 (s, 3H), 1.50 (d, J = 7.2 Hz, 3H), 1.49 (s, 3H); 13C NMR (CDCl3, 500Hz) δ 152.9,151.8, 147.0, 135.0, 133.4, 127.1, 124.8, 124.4, 120.0, 99.8, 61.0, 60.7, 55.4, 26.8, 22.2, 21.1, 12.4. HRMS (EI) calcd for C18H24O3 [M+H]+: 289.1803; found, 289.1730.
  • 43.Dallacker VF, Leuther P, Westerop KW. Chemiker-Zeitung. 1989;113:97–102. [Google Scholar]
  • 44.Data for ester 15a: Methyl 4-isopropyl-2,3,8-trimethoxy-6-methyl-1-naphthalene-carboxylate: Colorless oil; 1H NMR (CDCl3, 500Hz) δ 7.53 (s, 1H), 6.65 (s, 1H), 4.00 (s, 3H), 3.94 (s, 3H), 3.93 (s, 3H), 3.92 (m, 1H), 3.91 (s, 3H), 2.50 (s, 3H), 1.49 (d, J = 7.2 Hz, 6H); 13C NMR (CDCl3, 500Hz) δ 169.2, 154.4, 150.1, 148.3, 136.6, 134.8, 131.1, 121.3, 117.6, 116.1, 107.0, 61.4, 60.6, 56.3, 52.0, 27.0, 22.4, 22.0. HRMS (EI) calcd for C19H24O5 [M+Na]+: 355.1624; found, 355.1615.
  • 45.Data for bromide 15c: Methyl 7-bromo-2,3,8-trimethoxy-6-methyl-4-isopropyl-1-naphthalenecarboxylate: White solid; mp 98–100°C; 1H NMR: δ 7.77 (s, 1H), 3.96 (s, 3H), 3.90 (s, 6H), 3.82 (s, 3H), 3.81 (m, 1H), 2.54 (s, 3H), 1.45 (d, J = 7.2 Hz, 6H); 13C NMR: δ 168.4, 152.4, 150.4, 149.6, 137.1, 135.4, 129.8, 122.2, 121.2, 120.9, 116.4, 61.9, 61.5, 60.8, 52.3, 27.1, 24.2, 22.0. HRMS (EI) calcd for C19H23BrO5 [M+H]+: 411.0807; found, 411.0740.
  • 46.Data for lactones 4: 3,4-Dihydroxy-4-isopropyl-6-methyl-1,8-naphtholactone 4a: White solid; mp 220–222 °C; 1H NMR (CDCl3, 500Hz) δ 8.70 (br s, 1H), 7.51 (s, 1H), 6.92 (s, 1H), 6.08 (s, 1H), 3.93 (m, 1H), 2.55 (s, 3H), 1.49 (d, J = 7.2 Hz, 6H); 13C NMR: (Acetone-d6, 500Hz) δ 166.1, 149.3, 148.0, 147.8, 136.3, 135.7, 124.4, 122.3, 117.7, 106.1, 100.9, 28.1, 22.9, 21.0. HRMS (EI) calcd for C15H14O4 [M+H]+: 259.0970; found, 259.0970. 7-Bromo-2,3-dihydroxy-4-isopropyl-6-methyl-1,8-naphtho-lactone 4c: White solid; mp 254–255 °C; 1H NMR (Acetone-d6, 500Hz) δ 7.78 (d, J = 1.0 Hz, 1H), 3.89 (m, 1H), 2.57 (d, J = 1.0 Hz, 3H), 1.49 (d, J = 7.2 Hz, 6H); 13C NMR (Acetone-d6, 500Hz) δ 164.7, 148.3, 147.6, 147.5, 136.6, 135.5, 123.4, 123.2, 119.8, 101.2, 100.0, 28.4, 23.4, 21.0. HRMS (EI) calcd for C15H13BrO4 [M+H]+: 337.0075; found, 337.0088.
  • 47.Lohaus G. Chem. Ber. 1967;100:2719–2723. [Google Scholar]
  • 48.Data for compounds 16 and 17: 4-isopropyl-2,3-dimethoxy-6,7-dimethyl-1,8-naphtholactone 16: Oil; 1H NMR (CDCl3, 500Hz) δ 7.59 (s, 1H), 4.56 (s, 3H), 3.86 (s, 3H), 3.85 (m, 1H), 2.47 (s, 3H), 2.39 (s, 3H), 1.51 (d, J = 7.2 Hz, 6H); 13C NMR (CDCl3, 500Hz) δ 165.6, 155.0, 149.8, 146.7, 144.9, 136.3, 124.6, 122.1, 118.5, 116.1, 103.3, 62.5, 61.6, 27.7, 22.2, 20.9, 11.9. HRMS (EI) calcd for C18H20O4 [M+H]+: 301.1440; found, 301.1435. 5-Carboxamido-4-isopropyl-2,3-dimethoxy-6,7-dimethyl-1,8-naphtholactone 17: Solid; mp 259–260 °C; 1H NMR: (Acetone-d6, 500Hz) δ 4.50 (s, 3H), 4.22 (m, 1H), 3.94 (s, 3H), 2.44 (s, 3H), 2.37 (s, 3H), 1.43 (d, J = 6.5 Hz, 3H), 1.33 (d, J = 6.5 Hz, 3H); 13C NMR (Dimethylformamide-d7, 500 MHz) δ 173.4, 164.9, 155.5, 153.4, 146.4, 146.3, 134.2, 130.2, 124.2, 120.2, 116.3, 104.7, 62.6, 61.7, 28.8, 21.4, 21.3, 16.9, 12.2. HRMS (EI) calcd for C19H21NO5 [M+H]+: 344.1498; found, 344.1498.

RESOURCES